For Topical (Skin Cancer) Applications
"Please read carefully before using!"
The medical definition of "cure" is the non-reoccurence of
pathology within five years after treatment. By the very definition
used by orthodox medicine, Cansema®
is empirically a proven
cure for skin cancer for the majority of those who
use the product according to our instructions.
An extensive history of Cansema®, in particular -- and
escharotics, in general -- can be found in Chapters 1 and 2
Note that we have special protocols for use in treating internal
cancers, but the instructions below are specific to skin cancer,
and a number of other diseased skin conditions.
There are numerous counterfeiters of Cansema®
who use our
graphics -- even
, even though they are not connected to us; the formula
is not the same; and the performance of their product is substandard to the genuine article!
We list known counterfeiters -- one of which we know is receiving FDA assistance
in making an adulterated / misbranded version -- on our
page. This Cansema® User Instructions
page is currently being recommended by a company
run by Jennifer Wilson / George Ackerson --
who are telling the public that they are us
Do not believe it. We do not and will not
provide customer service for their products.
Please read the following instructions
through carefully before applying Cansema
®. Do not, in any
way, deviate from the following. If you have questions after
a thorough reading, please call Alpha Omega
clarification, or just write to firstname.lastname@example.org
® will provide results only
if you have skin cancer, as opposed to a benign growth. This
includes basal cell and squamous cell carcinomas
of the skin.
on an alternative to benign moles and warts, see
--- (1) PREPARATION ---
Understand at the onset that applications to the face / nose / and ears, breast,
and the rest of the body should be treated differently.
Additional advisements before preceeding include:
- Face / Nose / Ears:
Never apply to an area larger than the end of a pencil eraser (roughly
1/4 inch or a little over one-half centimeter. Inflammation can be
considerable, depending on the area to which you apply, as well as the
depth and size of the targeted growth.
- Breast: With certain exceptions, we don't recommend applying
Cansema to breast tumors. The process is long and arduous, and although
it may take longer, using an
internal escharotic approach
is easier, all things considered.
- Other Areas: Apply no more than one to two centimeters
(up to about an inch) to the targeted growth. If the growth is larger,
it must be worked on in stages.
- Areas to which you should NEVER apply:
- Eyelids: The thinness of the skin risks perforation and foreign bodies
entering the eye. Successful cases have involved serious guidance from a skilled
practitioner -- often our own in-house practitioners.
- The right or left temple: The temporal artery can readily be compromised,
leading to a serious bleeding problem. Since 1990, we have had three such cases,
and each of them required surgical intervention. Our advice: don't do it.
- Cervical lymphatic chain in the neck: Large vascular pockets are present in this area,
and they may be involved in the growth of the malignancy. An active arterial bleed in this area
can be fatal. Again, our advice: don't do it.
- Scrotum (in men) and vulval area (in women): In the case of the scrotum,
the removal of a larger growth escharotically can risk the ejection of a testicle.
In the case of applications on or near the vulva, pain management can be a significant
issue, and all the successful cases we know of that involve the treatment of cancers
in and around the vagina have involved the experienced guidance of a practitioner who
is skilled in the use of escharotic preparations. If you have questions about this,
please consult one of our in-house practitioners.
First, as stated earlier,
the user may want to have an antigen test or other non-invasive diagnostic procedure
performed to ascertain whether or not there is, in fact,
skin cancer. People should be aware of the very well-established risks associated with
biopsies or otherwise cutting into the cancer growth.
- Cansema® should only be applied between one to three times (24 hours apart)
per escharotic cycle, which is described on our pictorial
demonstration page. More is not better. Once a white/yellowish plaque of sterile pus forms,
no more applications are needed at that point. Adding more salve is not helpful.
Most superficial skin lesions need only one application.
- If you're treating multiple growths, in the interests of
pain management, treat only
one growth at a time. It is also recommended so that the treatment
does not overwhelm the body's immune system. This advice is self-evident
if you understand Cansema's mechanism of action.
- The application of the salve over diseased cells (cancerous or precancerous)
produces an acute immune response. This response is followed by a localized
inflammatory response. The inflammation will gradually reduce over the next
few days after the initial application.
- Understand that the white or colored pus that forms is cellular detritus -- that is, dead cells --
or a combination of your own white blood cells and dead diseased cells. We know
this as a result of pathology reports on eschars that have come back to us.
(You can do this yourself if you keep a freshly ejected eschar preserved in formaldehyde.)
- Do NOT disturb this freshly formed scab, or eschar, as this increases the risk
of scar tissue formation. Do not cut into it. Do not pinch it. Do not try to drain it.
Leave it alone! Be patient! Another reason for leaving the eschar alone is that the dead cells
hold together such that when the eschar ejects, you get a nice, clean separation, leaving
only a decavitation that subsequently fills in.
- Most confirmed diagnoses of malignancy (melanoma, BCC, SCC, etc.) need multiple cycles
of escharotic treatment before there is no longer a reaction. Larger malignancies grow with
tentacles and deep roots. All confirmed diagnoses should start with an internal protocol
as a preventative. See Botanical Support.
- Understand that infection is very rare with the use of Cansema. Out of thousands of
cases with which we have worked since 1990, we have seen only a handful of cases of infection,
and even in these cases, the growth was of a considerable size. We say this because most
medical doctors have no training or knowledge of escharotic medicine. Consequently, when they
see the edema, inflammation, and eschar formation that is integral to this process, they
automatically think they're looking at an infection and prescribe antibiotics. This is
unnecessary because the entire escharotic process is mediated by your own immune system.
Many people, on the observation that they have a "mole" or
similar skin marking that is growing and getting darker, have elected
to use Cansema® anyway. After all, Cansema® is selective
in its action and will only "go after" neoplastic (cancerous), precancerous and
similar diseased tissue.
Healthy tissue will only redden and become mildly irritated when
Cansema® is applied. This decision is entirely at the
discretion of the user; there is no danger, toxic or otherwise,
of applying Cansema® to healthy tissue, although doing
so is simply a waste of the product.
PREPPING CANSEMA® SALVE:
Few escharotic salves, if
any (and Cansema® is no exception), use emulsifying agents,
so to get the best results from Cansema®, you should
spend a few seconds stirring the contents before applying.
For the smaller (22 g.) container, this can be done with
a toothpick; for the "clinical sized" jar, we find the
best implement to be an ice cream stick.
You will find the latter's consistency yields the best results.
Note on Altering Consistency:
Not everyone wants the same consistency in a salve. Some users have
noted that their Cansema®
is thicker than they want it. (Thickening
can also occur if Cansema is left out and allowed to dry up.) The solution
to thinning the product is simple. Since Cansema® is water-soluble, just
add a few drops of water to the desired consistency, while -- again --
stirring vigorously. Doing this will not appreciably affect the
strength or efficacy of the product
--- (2) APPLICATION ---
Cansema® comes in both small 22 gram (roughly 0.8 oz.)
and "clinical-sized" 102 gram (roughly 3.6 oz.) jars.
The product has the consistency of a thick, moist paste.
It can easily be self-applied with the fingers and should be spread
over the lesion or cancerous tissue in a thin covering, almost
lightly "caked." Wash hands thoroughly before and after applying
The following is observed following the
application of the product when diseased tissue is detected:
- The applied area will start to tingle shortly afterwards -- anywhere
between 5 minutes to 6 hours after the initial application. (In fact,
if you feel "nothing" after three to six hours, it is most likely
that nothing more will happen: Cansema® has failed to come into
direct contact with the cancer.)
- After 24 hours, you may wish to
remove the Cansema® and reapply, repeating this process up to three times, until
the Cansema® can reach and "grab" the underlying aberrant
growth. Know that anywhere from one to three applications are normally
required initially to escharize a skin cancer. However, if the growth is
considerably larger, two or three complete
escharotic cycles may be required to eradiate a malignancy in its entirety.)
- In some cases, there is a burning sensation with larger lesions.
For this reason, we ask that users thoroughly read our
pain management page.
- It is also a good idea to place
a bandage over the area, particularly if the forming eschar is
on a place on the body that might be subject to being bumped
or bruised in the course of daily activity. For practical,
aesthetic, and cleanliness issues, covering the
site is a good idea. We recommend lining the bandage or
gauze with a healing salve, cream, or ointment so prevent
sticking to the eschar. If sticking occurs, wet the bandage
or gauze completely and remove slowly. Again, the point here
is to NOT disturb the eschar.
" . . . I applied Cansema® and no eschar appeared! . . . What do I do now?"
Cansema® has to come into contact with the
target cancer area in order to work. It has transdermal properties (i.e. skin
penetrating ability) - a characteristic that is enhanced with the
Cansema® - Deep Tissue
, as well as our
versions. However, a couple of
simple tricks can also speed up the process and/or reduce the number of
applications required to "reach" a skin cancer that is well below the
epidermis. Most people don't need these techniques if the skin cancer is
close to the skin surface. We recommend that these "tricks of the trade"
only be used if an initial application does not produce results - which
turns out to be a minority of cases.
"Deep Loufah Wash" -
wash and prepare the skin before applying Cansema® Salve.
This serves to remove some of the dead cells in the top layer of the
), so that Cansema® has less tissue through which to travel to get to the underlying cancer.
"Needle Points" -
is more effective, but more invasive. It involves taking a sterilized needle
and carefully making holes in the skin - about a sixteenth to eighth inch
deep, very much as an acupuncturist would - except that the needle is removed
as soon as the holes are created, usually spaced about a quarter-inch apart. Following
the creation of the "skin holes," Cansema® Salve is then (re)applied.
We recommend that this technique be used by practitioners and not end users.
We also advise that practitioners prep the area by rubbing three drops of
into the freshly "pricked" skin before
Cansema® is (re)applied, provided that the subject is not diabetic - a clear
contraindication, in which case hydrogen peroxide (3-6%) will act as a
--- (3) MANAGING THE ESCHAR ---
The following should be observed in managing
the resulting eschar:
- After 24 hours remove the bandage.
- Wash the area thoroughly with clean water and a gentle soap to
remove any excess Cansema® and other organic
debris (i.e. pus, serous fluid, etc.) Some salve can become part
of the white plaque. Do NOT forcefully remove. Leave it alone.
It will become part of the eschar.
- If a full pus formation
is not evident or is incomplete, repeat step 2 and leave the
new application on for an additional 24 hours before proceeding.
Normally one application is sufficient for small growths (a few
milliters in diameter), but several applications or entire cycles may be
required for larger tumors.
- There are instances when repeated applications
of Cansema® are required because of "accessibility" problems -
although this can be limited using the techiques cited in
the preceding section. In order to
initiate the escharization process, however, and begin killing the malignancy,
it is vital that Cansema® be able to penetrate and reach
the targeted growth. Again, this can take multiple (three or more) applications,
though one to two applications for smaller growths is more common.
- After the eschar has formed, keep it well protected. You can apply
Sangre de Drago, H3O,
among other topicals in treating the area.
(H3O is also known as "Calcium Sulfate Hydronium Solution" in our U.S. and Canadian markets).
H3O should be diluted with purified water at the
16:1 ratio to accelerate healing - but know
that this is better to use once you reach the decavitation stage.
(Although recent reports have been submitted where H3O
was used throughout the entire process as a cleaning agent - acting to
accelerate healing and minimize scaring.)
- Wash over the area daily with clean water and gentle soap.
We do not recommend "soaking" the eschar. This includes swimming,
sitting in a bathtub, or otherwise subjecting the site to anything
more than minimal exposure to water. The reason for this is that this
part of the escharotic cycle involves the drying up, contraction, and
ejection of the eschar. If you're keeping the area wet, this process
is only inhibited.
- In advanced cases there is considerable "drainage," that is,
a steady emission of pus. In the sense that Cansema® kills
the cancer cells and takes certain leukocytes (defending white
blood corpuscles) with it in the process of eliminating the
neoplasm, it is a suppurative agent: that is, drainage should
not be viewed as abnormal. The range of possible response is very little
pus and only one bandage ever required, to a regular change of
bandages required in the case of advanced melanomas. Your case will be
- Time to ejection: This will vary from case to case, depending
primarily on the depth and size of the target growth. This averages
between ten to sixty days. Those that are closer to the sixty day
mark tend to be massive growths.
--- (4) REMOVING THE ESCHAR ---
The eschar itself represents
the death of the neoplasm, and this occurs shortly after application.
Everything that follows from there is the body's own reparative responses.
From here on out, the body knows exactly what to do and wastes no
time doing it. However, to us the days and weeks that follow
may seem lengthy.
The next stage is the removal of the eschar, or scab. This usually
happens, as stated previously, within 10 to 60 days after initial application.
As with any scab, let it fall out when it is ready. Do NOT pull it out
prematurely, although you may find that it will eventually be
attached with a small thread of connective tissue which can be easily
and safely severed. If you remove the eschar premature, you
further risk developing scar tissue. Also, know that
if the eschar is slow in ejecting on its own, there are
simple methods of quickening the process.
--- (5) DECAVITATION & "HEALING OVER" ---
After the eschar comes out,
the pit or "decavitation" can look raw and unsightly. Nonetheless,
if kept covered and the everyday principles of good hygiene are
followed, there will be no threat of secondary infection.
If you work in area that is less than clean, however, you might
want to have H3O handy. You can apply
this liberally at the 16:1 dilution ratio
to the site once a day to kill any invasive germs. Another option is the use of
Sangre de Drago --
a natural tree resin, sold
by Alpha Omega Labs which also accelerates the healing
Over a period of a few months, or in some cases two years,
the entire area will be healed with only some "depigmentation"
or scar tissue. The result is rarely more unsightly or unaesthetic
than if surgery had been chosen instead.
In most cases the cancer does not "come back" to the
area applied, unless there is underlying metastasis. To be sure
that the area is clear of cancer, however, many users elect to initiate
a second, or even third, application after they get to the
"heal over" stage. We take a dim view to doing this indiscriminately
because the risk of scarring is increased with each new re-application.
However, with particularly aggressive forms of cancer, such as
melanoma, a user may want to weigh the potential advantages of
re-application, particularly if the initial cancer is located
somewhere on the body that is not usually aesthetically sensitive
or viewed in public (i.e. on the back, upper leg, etc.). None
of this should be taken as a substitute for using some of the better
cancer marker tests that are now available from qualified,
In other words, once
Cansema® has finished its work, there
are normally no residual cells from the original malignancy.
This rule finds more exceptions the larger the original cancer
growth is, the deeper it is beneath the skin, the more instances
of skin cancer the subject has experienced, and/or the more
extensive a person's history of skin cancer is or has been.
Remember, you may need to repeat this process if the skin cancer
is sufficiently extensive such that residual cancer cells have
been left behind after you finish your first "cycle." (Although,
this same admonition would exist if you had your skin cancer
surgically removed.) To be on the side of caution, have your
health care practitioner check the site to see if there is
any remaining cancer. There are excellent antigen marker
tests that your physician can utilize to determine if you
have a "clean bill of health."
Back to Cansema® Opening Page |
Home Page |